Skip to content
Subscriber Only
Markets Magazine

Billionaire Doctor Prescribes Small Teva Deals for Israeli Giant


As American billionaire Phillip Frost prepared to take over as chairman of Teva Pharmaceutical Industries Ltd. in March 2010, some investors fretted about what would become of Israel’s crown jewel.

Eli Hurvitz, a national icon who had won the government’s Israel Prize for his lifelong contributions to the country, had set a patriotic tone at the world’s largest generic-drug maker before stepping down that year to fight his own cancer.